Geode Capital Management, LLC Angion Biomedica Corp. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.48 - $1.02 $495 - $1,053	-1,033 Reduced 0.61%	167,403 $97,000
Q4 2022 Feb 13, 2023	SELL	$0.8 - $1.0 $360 - $451	-451 Reduced 0.27%	168,436 $136,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $1.23 $77,023 - $100,786	81,940 Added 94.24%	168,887 $155,000
Q2 2022 Aug 12, 2022	SELL	$1.1 - $2.23 $174,820 - $354,409	-158,928 Reduced 64.64%	86,947 $99,000
Q1 2022 May 13, 2022	BUY	$1.72 - $2.96 $36,501 - $62,817	21,222 Added 9.45%	245,875 $521,000
Q4 2021 Feb 11, 2022	SELL	$2.35 - $9.95 $63,605 - $269,306	-27,066 Reduced 10.75%	224,653 $651,000
Q3 2021 Nov 12, 2021	BUY	$9.31 - $13.25 $1.4 Million - $1.99 Million	150,429 Added 148.51%	251,719 $2.46 Million
Q2 2021 Aug 13, 2021	BUY	$13.02 - $17.83 $77,911 - $106,694	5,984 Added 6.28%	101,290 $1.32 Million
Q1 2021 May 12, 2021	BUY	$15.01 - $25.74 $1.43 Million - $2.45 Million	95,306 New	95,306 $1.72 Million

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.